InVivoMAb anti-mouse 4-1BB (CD137)

Taechangam N, Iyer SS, Walker NJ, et al. Mechanisms utilized by feline adipose-derived mesenchymal stem cells to inhibit T lymphocyte proliferation. Stem Cell Res Ther. 2019,10(1):188. doi: 10.1186/s13287-019-1300-3

Azpilikueta A, Agorreta J, Labiano S, et al. Successful Immunotherapy against a Transplantable Mouse Squamous Lung Carcinoma with Anti-PD-1 and Anti-CD137 Monoclonal Antibodies. J Thorac Oncol. 2016,11(4):524-36. doi: 10.1016/j.jtho.2016.01.013

Eun SY, Lee SW, Xu Y, et al. 4-1BB ligand signaling to T cells limits T cell activation. J Immunol. 2015,194(1):134-41. doi: 10.4049/jimmunol.1401383

Fuse S, Bellfy S, Yagita H, et al. CD8+ T cell dysfunction and increase in murine gammaherpesvirus latent viral burden in the absence of 4-1BB ligand. J Immunol. 2007,178(8):5227-36.

Nishimoto H, Lee SW, Hong H, et al. Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor. Blood. 2005,106(13):4241-8.

Zheng G, Wang B, Chen A. The 4-1BB costimulation augments the proliferation of CD4+CD25+ regulatory T cells. J Immunol. 2004,173(4):2428-34.